|
Segment Disclosures (Schedule of Segment Reporting Information) (Details) (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Segment Reporting Information [Line Items] | ||
| Revenue | $ 3,301,944 | $ 2,706,577 |
| Cost of revenue | 2,714,634 | 2,336,277 |
| Gross Profit | 587,310 | 370,300 |
|
Engineering Services [Member]
|
||
| Segment Reporting Information [Line Items] | ||
| Revenue | 1,690,235 | 2,140,355 |
| Cost of revenue | 1,253,942 | 1,782,848 |
| Gross Profit | 436,293 | 357,507 |
|
Medical Devices [Member]
|
||
| Segment Reporting Information [Line Items] | ||
| Revenue | 1,611,709 | 566,222 |
| Cost of revenue | 1,460,692 | 553,429 |
| Gross Profit | $ 151,017 | $ 12,793 |
| X | ||||||||||
|
- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|